Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. The company employs 24,379 full-time employees. The company went IPO on 2003-12-08. The firm operates through three business segments. The Modernized Chinese Medicine and Chemical Medicine segment is engaged in the manufacture, sale and distribution of modernized Chinese medicine products and western medicine products. The Investment segment is principally engaged in the long-term and short-term investments. The Other segment is principally engaged in the related medical and hospital business.
Mr. S. Y. Tse is the Chief Executive Officer of Sino Biopharmaceutical Limited, joining the firm since 2019.
What is the price performance of Sino Biopharmaceutical Ltd. stock?
The current price of Sino Biopharmaceutical Ltd. is $15.89, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Sino Biopharmaceutical Limited?
Sino Biopharmaceutical Limited belongs to Pharmaceuticals industry and the sector is Health Care
What is Sino Biopharmaceutical Limited market cap?
Sino Biopharmaceutical Limited's current market cap is $14.2B
Is Sino Biopharmaceutical Limited a buy, sell, or hold?
According to wall street analysts, 26 analysts have made analyst ratings for Sino Biopharmaceutical Limited, including 10 strong buy, 18 buy, 2 hold, 0 sell, and 10 strong sell